Differential motility of p190bcr-abl- and p210 bcr-abl-expressing cells: Respective roles of Vav and Bcr-Abl GEFs

Oncogene

Volumn 27, Issue 19, 2008, Pages 2673-2685

  Daubon, T ^a   Chasseriau, J ^a   Ali, A El ^a   Rivet, J ^b   Kitzis, A ^a,b   Constantin, B ^a   Bourmeyster, N ^a,b,c  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c UMR 6187   (France)

Author keywords

Amoeboid; Bcr Abl; Motility; Rho; Vav

Indexed keywords

BCR ABL PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN P190; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA; VAV PROTEIN; DNA BINDING PROTEIN; GRLF1 PROTEIN, MOUSE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; REPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CELL MOTION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC TRANSFECTION; IMMOBILIZED CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; BIOSYNTHESIS; CELL LINE; COMPARATIVE STUDY; DRUG ANTAGONISM; GENETICS; LEUKOCYTE MIGRATION INHIBITION TEST; METABOLISM; ONCOGENE; PHYSIOLOGY; RNA INTERFERENCE;

ANIMALS; CELL LINE; CELL MIGRATION INHIBITION; CELL MOVEMENT; DNA-BINDING PROTEINS; FUSION PROTEINS, BCR-ABL; GENES, ABL; GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MICE; PROTO-ONCOGENE PROTEINS C-VAV; RAC1 GTP-BINDING PROTEIN; REPRESSOR PROTEINS; RNA INTERFERENCE;

EID: 42549093634     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210933     Document Type: Article

References (27)

1. Bassermann F, Jahn T, Miething C, Seipel P, Bai RY, Coutinho S et al. (2002). Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway. J Biol Chem 277: 12437-12445.
2. Bhatia R, Munthe HA, Verfaillie CM. (1999). Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors. Exp Hematol 27: 1384-1396.
3. Bustelo XR. (2000). Regulatory and signaling properties of the Vav family. Mol Cell Biol 20: 1461-1477.
4. Chuang TH, Xu X, Kaartinen V, Heisterkamp N, Groffen J, Bokoch GM. (1995). Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 92: 10282-10286.
5. Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW et al. (1988). Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science 239: 775-777.
6. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR. (1997). Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385: 169-172.
7. Daley GQ, Baltimore D. (1988). Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc Natl Acad Sci USA 85: 9312-9316.
8. Daley GQ, Van Etten RA, Baltimore D. (1990). Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247: 824-830.
9. Deininger MW, Goldman JM, Melo JV. (2000). The molecular biology of chronic myeloid leukemia. Blood 96: 3343-3356.
10. Friedl P, Wolf K. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
11. Harnois T, Constantin B, Rioux A, Grenioux E, Kitzis A, Bourmeyster N. (2003). Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl. Oncogene 22: 6445-6454.
12. Hernandez SE, Krishnaswami M, Miller AL, Koleske AJ. (2004). How do Abl family kinases regulate cell shape and movement? Trends Cell Biol 14: 36-44.
13. Ilaria Jr RL, Van Etten RA. (1996). p210and p190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 271: 31704-31710.
14. Lugo TG, Pendergast AM, Muller AJ, Witte ON. (1990). Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247: 1079-1082.
15. Marvaud JC, Stiles BG, Chenal A, Gillet D, Gibert M, Smith LA et al. (2002). Clostridium perfringens iota toxin. Mapping of the Ia domain involved in docking with Ib and cellular internalization. J Biol Chem 277: 43659-43666.
16. Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B, Griffin JD. (1995). Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL. EMBO J 14: 257-265.
17. Nakashima S, Nozawa Y. (1999). Possible role of phospholipase D in cellular differentiation and apoptosis. Chem Phys Lipids 98: 153-164.
18. Raftopoulou M, Hall A. (2004). Cell migration: Rho GTPases lead the way. Dev Biol 265: 23-32.
19. Salgia R, Li JL, Ewaniuk DS, Pear W, Pisick E, Burky SA et al. (1997). BCR/ABL induces multiple abnormalities of cytoskeletal function. J Clin Invest 100: 46-57.
20. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F et al. (1998). Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143: 1385-1398.
21. Sawyers CL. (1999). Chronic myeloid leukemia. N Engl J Med 340: 1330-1340.
22. Stasia MJ, Jouan A, Bourmeyster N, Boquet P, Vignais PV. (1991). ADP-ribosylation of a small size GTP-binding protein in bovine neutrophils by the C3 exoenzyme of Clostridium botulinum and effect on the cell motility. Biochem Biophys Res Commun 180: 615-622.
23. Unwin RD, Sternberg DW, Lu Y, Pierce A, Gilliland DG, Whetton AD. (2005). Global effects of BCR/ABL and TEL/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL. J Biol Chem 280: 6316-6326.
24. Van Etten RA. (1999). Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends Cell Biol 9: 179-186.
25. Wertheim JA, Forsythe K, Druker BJ, Hammer D, Boettiger D, Pear WS. (2002). BCR-ABL-induced adhesion defects are tyrosine kinase-independent. Blood 99: 4122-4130.
26. Yamazaki D, Kurisu S, Takenawa T. (2005). Regulation of cancer cell motility through actin reorganization. Cancer Sci 96: 379-386.
27. Zheng J, Chen RH, Corblan-Garcia S, Cahill SM, Bar-Sagi D, Cowburn D. (1997). The solution structure of the pleckstrin homology domain of human SOS1. A possible structural role for the sequential association of diffuse B cell lymphoma and pleckstrin homology domains. J Biol Chem 272: 30340-30344.